Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.

Sudong Xue,Zheng Wang,Jiantong Sun,Wei Wu,Caihong Tan,Linjun Xie,Xinyuan Ding,Guangxian Lu,Xiaoyu Wang,Xing Jin,Wenjuan Wang,Ziyan Wang

doi:10.3389/fphar.2020.00948

Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.

Sudong Xue, Zheng Wang + Show 10 more

Open Access

https://doi.org/10.3389/fphar.2020.00948

Copy DOI

Journal: Frontiers in Pharmacology	Publication Date: Jun 24, 2020
Citations: 16	License type: CC BY 4.0

Affiliation: Ruijin Hospital, Shanghai Jiao Tong University, Suzhou Municipal Hospital, Nanjing Medical University, First Affiliated Hospital of Sun Yat-sen University, Zhongshan Hospital, Fudan University, Sun Yat-sen University, Soochow University

#Ubiquitin-specific Protease 5 #Invasion Of Non-small Cell Lung Cancer Cells + Show 8 more

Abstract
Highlights/Summary
Full-Text PDF
Similar Papers

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00668.].

Highlights

Corrigendum: ubiquitin-specific protease 5 (USP5) Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing EpithelialMesenchymal Transition via Wnt/bCatenin Pathway
Specialty section: This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
The correspondence order was incorrect in the original article

Summary

Introduction

Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing EpithelialMesenchymal Transition via Wnt/bCatenin Pathway. Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Results

Conclusion